شنبه 17 خرداد 1404
[Archive]
دوره 19، شماره 74 - ( 1-1390 )
جلد 19 شماره 74 صفحات 107-96 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shoghli A R, mousavinasab S N, Fallahnezhed M, Momtazi S, Tavasoli Shirvan S, Haji Karim B. Behavioral Surveillance Survey (BSS) Among Injection Drug Users (IDUs) in Zanjan-Iran. J Adv Med Biomed Res 2011; 19 (74) :96-107
URL: http://journal.zums.ac.ir/article-1-1421-fa.html
URL: http://journal.zums.ac.ir/article-1-1421-fa.html
شغلی علیرضا، موسوی نسب سیدنورالدین، فلاح نژاد مجتبی، ممتازی سعید، توسلی شیروان سیمین، حاجی کریم بهرام. مطالعه‌ی رفتاری مصرف کنندگان تزریقی مواد در شهر زنجان. Journal of Advances in Medical and Biomedical Research. 1390; 19 (74) :96-107
علیرضا شغلی*1 
، سیدنورالدین موسوی نسب ، مجتبی فلاح نژاد ، سعید ممتازی ، سیمین توسلی شیروان ، بهرام حاجی کریم
، سیدنورالدین موسوی نسب ، مجتبی فلاح نژاد ، سعید ممتازی ، سیمین توسلی شیروان ، بهرام حاجی کریم
1- ، shoghli@zums.ac.ir
چکیده: (173974 مشاهده)
Background and Objective: Injection Drug Users (IDUs) include more than 69.9% of known HIV/AIDS cases in Iran. The most important causes of HIV among them are syringe sharing and high risk behaviours such as sexual practice with different partners. Since IDUs are hard to reach and there is little information about them, this behavioural survey conducted to explore Zanjan district’s injection drug users in relation to HIV/AIDS.
Materials and Methods: In this descriptive-cross sectional study, 61 IDUs, inhabitants of Zanjan, were selected in non-random sampling by referring to the most probable sites and places of their presence. Data was collected using a standard Family Health Behavioral Surveillance Survey (BSS) questionnaire designed especially for IDUs.
Results: Mean duration of non injected and injected drug use was 12.1±5 and 4.5±3.5 years respectively, and age of the first injection was 24±5.4 years. The most frequently injected drug was Heroin (96.7%) and the most non-injected one was Cannabis (85.2). 55.7% of IDUs injected 4 or more times per day, and 32.8% reported needle sharing. 100% of the subjects knew the role of used syringe in HIV transmitting. 44.3% had taken an HIV test, and 70.4% knew about their HIV status.
Conclusion: The early age of starting drug injection, needle sharing, coverage of voluntary HIV testing in less than 25%, and unawareness of 1/3 of them about their HIV test status indicate the significance of priority and service delivery to this most high risk group.
نوع مطالعه: مقاله پژوهشی |
دریافت: 1389/12/17 | پذیرش: 1393/4/2 | انتشار: 1393/4/2
دریافت: 1389/12/17 | پذیرش: 1393/4/2 | انتشار: 1393/4/2
فهرست منابع
1. Razzaghi EM, Rahimi Movaghar A, Green TC, Khoshnood K. Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran. Harm Reduct J. 2006; 3: 12-25. [DOI:10.1186/1477-7517-3-12] [PMID] [PMCID]
2. Rahimi Movaghar A, Mohammad K, Razzaghi EM. Trend of drug abuse situation in Iran: a three decade survey. Hakim Res J. 2002; 5: 171-81.
3. Wodak A, Ali R, Farrell M. HIV in Injecting drug users in Asian countries. Editorial. BMJ. 2004; 329: 697-8. [DOI:10.1136/bmj.329.7468.697] [PMID] [PMCID]
4. Tait R. "Iran faces up to its most lethal threat-drugs". The Guardian. 2005. [cited 2005 Oct 27]. Available from URL: http://www.guardian.co.uk/ world/2005/oct/27/iran.roberttait
5. Ministry of Health and Medical Education, Centre for Diseases Management, Latest statistics about HIV infection in the Islamic Republic of Iran. 2009. Available from URL: http://www.mums.ac.ir/shares/aids/bahrainis4/PDF/AIDS88_2.pdf
6. Singer M, Stopka T, Siano C, et al. The social geography of AIDS and hepatitis risk: qualitative approaches for assessing local differences in sterile-syringe access among injection drug users. Am J Public Health. 2000; 90: 1049-56. [DOI:10.2105/AJPH.90.7.1049] [PMID] [PMCID]
7. Gollub EL, Rey D, Obadia Y, Moatti JP. Gender differences in risk behaviors among HIV+ persons with an IDU history. The link between partner characteristics and women's higher drug-sex risks. The Manif 2000 Study Group. Sex Transm Dis. 1998; 25: 483-8. [DOI:10.1097/00007435-199810000-00008] [PMID]
8. Poundstone KE, Strathdee SA, Celentano DD. The social epidemiology of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. Epidemiol Rev. 2004; 26: 22-35. [DOI:10.1093/epirev/mxh005] [PMID]
9. Friedman SR. Promising social network research results and suggestions for a research agenda. NIDA Res Monogr. 1995; 151: 196-215. [DOI:10.1037/e495782006-012]
10. Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003; 22: 332-9. [DOI:10.1037/0278-6133.22.4.332] [PMID]
11. Trotter RT, Bowen AM, Potter JM. Network models for HIV outreach and prevention programs for drug users. NIDA Res Monogr. 1995; 151: 144-80. [DOI:10.1037/e495782006-010]
12. Amon J, Brown T, Hogle J, et al. Behavioral Surveillance Surveys (BSS): Guidelines for Repeated Behavioral Surveys in Populations at Risk of HIV. Family Health International, 2000. Available from URL: http://www.who.int/hiv/ strategic/en/bss_fhi2000.pdf
13. Zamani S, Kihara M, Gouya MM, et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr. 2006; 42: 342-6. [DOI:10.1097/01.qai.0000219785.81163.67] [PMID]
14. Zamani S, Kihara M, Gouya MM, et al. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS. 2005; 19: 709-16. [DOI:10.1097/01.aids.0000166094.24069.72] [PMID]
15. Razzaghi EM, Rahimi A, Hosseini M, Madani S, Chatterjee A. Rapid situation assessment (RSA) of drug abuse in Iran. Prevention Department, State Welfare Organization, Ministry of Health, I.R. of Iran and United Nations International Drug Control Program. 1998-1999. Available from URL: www.unodc.org/pdf/iran /publications/ RSA2000SUMMARY.pdf
16. Narenjiha H, Rafiey H, Baghestani AH, et al. Rapid Situation Assessment of Drug Abuse and Drug Dependence in Iran (2004). Dariush Institute of Education and Research of Substance Abuse (In Farsi, not published).
17. Khani M, Vakili MM. Prevalence and risk factors of HIV, hepatitis B virus and hepatitis C virus infections in drug addicts among Zanjan prisoners. Arch Iranian Med. 2003; 6: 1-4.
18. Day C, Nassirimanesh B, Shakeshaft A, Dolan K. Patterns of drug use among a sample of drug users and injecting drug users attending a General Practice in Iran. Harm Reduct J. 2006; 3: 2. [DOI:10.1186/1477-7517-3-2] [PMID] [PMCID]
19. Zamani S, Vazirian M, Nassirimanesh B, et al. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program. AIDS Behav. 2008; 16: 10.1007/s10461-008-9404-2. [DOI:10.1007/s10461-008-9404-2] [PMID]
20. Rowhani Rahbar A, Rooholamini S, Khoshnood K. Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUs) in Mashhad, Iran. Int J Drug Policy. 2004; 15: 151-5. [DOI:10.1016/j.drugpo.2003.07.001]
21. Islamic Republic of Iran Country Report on Monitoring of the United Nations General Assembly Special Session on HIV and AIDS. Office of the Under-secretary for Health, Ministry of Health and Medical Education, Centre for Diseases Management. 2006. Available from URL: http://www.behdasht.gov.ir/ uploads/Iran%20UNGASS%20report%202008%20ver14%20Persian_9179.pdf
22. Vazirian M, Nassirimanesh B, Zamani S, et al. Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: A cross-sectional study. Harm Reduct J. 2005; 2: 19. [DOI:10.1186/1477-7517-2-19] [PMID] [PMCID]
23. Mohammadi MR, Mohammad K, Khalaj Abadi Farahani F, et al. Reproductive knowledge, attitudes and behavior among adolescent males in Tehran, Iran. Int Fam Plan Perspect. 2006; 32: 35-44. [DOI:10.1363/3203506] [PMID]
24. Khodabandeh G, Fakhireh F, Naserinia MR, Foladi S. Prevalence of high-risk sexual behavior in drug users referred to the counseling center. Second Congress of High Risk Behaviors. 2007. Zahedan, Iran.
25. Mokri A. Brief overview of the status of drug abuse in Iran. Arch Iranian Med. 2002; 5: 184-90.
ارسال پیام به نویسنده مسئول
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
